{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:51:18Z","timestamp":1780599078920,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008431","name":"Department of Primary Industries","doi-asserted-by":"publisher","award":["AE456"],"award-info":[{"award-number":["AE456"]}],"id":[{"id":"10.13039\/100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008431","name":"Department of Primary Industries","doi-asserted-by":"publisher","award":["46.7)104 (54.2)97 (49.2"],"award-info":[{"award-number":["46.7)104 (54.2)97 (49.2"]}],"id":[{"id":"10.13039\/100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008431","name":"Department of Primary Industries","doi-asserted-by":"publisher","award":["COVID-1943"],"award-info":[{"award-number":["COVID-1943"]}],"id":[{"id":"10.13039\/100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008431","name":"Department of Primary Industries","doi-asserted-by":"publisher","award":["180\/160"],"award-info":[{"award-number":["180\/160"]}],"id":[{"id":"10.13039\/100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008431","name":"Department of Primary Industries","doi-asserted-by":"publisher","award":["6.8)10 (5.1"],"award-info":[{"award-number":["6.8)10 (5.1"]}],"id":[{"id":"10.13039\/100008431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.anai.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:04:53Z","timestamp":1752602693000},"page":"54-60.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Albuterol\u2013budesonide rescue inhaler for asthma"],"prefix":"10.1016","volume":"136","author":[{"given":"Bradley E.","family":"Chipps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Reynold A.","family":"Panettieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Skolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Cappelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Z.","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Dunsire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileen A.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2025.07.008_bib0001","unstructured":"Centers for Disease Control and Prevention. Most recent national asthma data. Accessed December 7, 2023. Available at: https:\/\/www.cdc.gov\/asthma\/most_recent_national_asthma_data.htm"},{"key":"10.1016\/j.anai.2025.07.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105919","article-title":"Multinational cohort study of mortality in patients with asthma and severe asthma","volume":"165","author":"Engelkes","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2025.07.008_bib0003","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2147\/JAA.S316278","article-title":"Health-related quality of life and health utilities of mild, moderate, and severe asthma: evidence from the Medical Expenditure Panel Survey","volume":"14","author":"Song","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.anai.2025.07.008_bib0004","unstructured":"Global Initiative for Asthma (GINA). Global Strategy Asthma Management and Prevention 2024. Accessed July 18, 2024. Available at: https:\/\/ginasthma.org"},{"issue":"22","key":"10.1016\/j.anai.2025.07.008_bib0005","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","article-title":"Albuterol-budesonide fixed-dose combination rescue inhaler for asthma","volume":"386","author":"Papi","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2025.07.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01521-2023","article-title":"Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme","volume":"64","author":"Jackson","year":"2024","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2025.07.008_bib0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anai.2024.11.015","article-title":"Steroid stewardship in allergy\/immunology: an opportunity for improved clinical outcomes","volume":"134","author":"Patrawala","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.anai.2025.07.008_bib0008","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/thx.2010.156489","article-title":"Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity","volume":"66","author":"Thamrin","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2025.07.008_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-6-13","article-title":"Attitudes and actions of asthma patients on regular maintenance therapy: the Inspire study","volume":"6","author":"Partridge","year":"2006","journal-title":"BMC Pulm Med"},{"issue":"9","key":"10.1016\/j.anai.2025.07.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2023.04.046","article-title":"A discrete choice experiment to assess patient preferences for asthma rescue therapy and disease management","volume":"11","author":"Israel","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.07.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2023.06.018","article-title":"Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation","volume":"131","author":"Lanz","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.07.008_bib0012","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1164\/ajrccm.160.2.9811100","article-title":"Exacerbations of asthma: a descriptive study of 425 severe exacerbations","volume":"160","author":"Tattersfield","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.anai.2025.07.008_bib0013","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.jaip.2022.03.029","article-title":"Insights from the AUSTRI study on reliever use before and after asthma exacerbations","volume":"10","author":"Busse","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.07.008_bib0014","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1152\/japplphysiol.00643.2020","article-title":"Exploring the sites and kinetics of bronchodilator response to \u03b2-2 agonists in asthma","volume":"130","author":"Demey","year":"2021","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.anai.2025.07.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01402-2021","article-title":"Short-acting \u03b22-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study","volume":"59","author":"Bateman","year":"2022","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.anai.2025.07.008_bib0016","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1007\/s12325-020-01444-5","article-title":"Asthma-related health outcomes associated with short-acting \u03b22-agonist inhaler use: an observational UK study as part of the SABINA global program","volume":"37","author":"Bloom","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.anai.2025.07.008_bib0017","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/JAA.S470975","article-title":"Patterns of rescue and maintenance medication claims surrounding an asthma exacerbation in patients treated as intermittent or mild persistent asthma","volume":"17","author":"Lanz","year":"2024","journal-title":"J Asthma Allergy"},{"issue":"5","key":"10.1016\/j.anai.2025.07.008_bib0018","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.anai.2025.02.009","article-title":"Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting \u03b22-agonist rescue","volume":"134","author":"Lugogo","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.07.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.anai.2025.07.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.02.047","article-title":"Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America","volume":"10","author":"Quint","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2025.07.008_bib0021","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.07.008_bib0022","unstructured":"Astra Zeneca PLC. Airsupra: prescribing information. Accessed July 27, 2023. Available at:https:\/\/den8dhaj6zs0e.cloudfront.net\/50fd68b9-106b-4550-b5d0-12b045f8b184\/fe598cda-d255-4446-998e-617607f61552\/fe598cda-d255-4446-998e-617607f61552_viewable_rendition__v.pdf"},{"key":"10.1016\/j.anai.2025.07.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241232264","article-title":"Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study","volume":"18","author":"Papi","year":"2024","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.anai.2025.07.008_bib0024","unstructured":"Global Initiative for Asthma (GINA). Global Strategy Asthma Management and Prevention 2023. Accessed December 7, 2023. Available at: https:\/\/ginasthma.org"},{"key":"10.1016\/j.anai.2025.07.008_bib0025","unstructured":"Global Initiative for Asthma (GINA). Global Strategy Asthma Management and Prevention 2020. Accessed December 8, 2023. Available at: https:\/\/ginasthma.org"},{"issue":"9643","key":"10.1016\/j.anai.2025.07.008_bib0026","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0140-6736(08)61450-6","article-title":"Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control","volume":"372","author":"Frey","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.anai.2025.07.008_bib0027","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200831110-00002","article-title":"Safety of inhaled budesonide","volume":"31","author":"Christensson","year":"2008","journal-title":"Drug Saf"},{"issue":"22","key":"10.1016\/j.anai.2025.07.008_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214207","article-title":"Salbutamol in the management of asthma: a review","volume":"23","author":"Marques","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.anai.2025.07.008_bib0029","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMoa2118813","article-title":"Reliever-triggered inhaled glucocorticoid in Black and Latinx adults with asthma","volume":"386","author":"Israel","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2025.07.008_bib0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaip.2023.01.010","article-title":"\u201cAs-needed\u201d inhaled corticosteroids for patients with asthma","volume":"11","author":"Cardet","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.07.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211042534","article-title":"Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies","volume":"15","author":"Canonica","year":"2021","journal-title":"Ther Adv Respir Dis"},{"issue":"4","key":"10.1016\/j.anai.2025.07.008_bib0032","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/jcm9040921","article-title":"Effective asthma management: is it time to let the AIR out of SABA?","volume":"9","author":"Kaplan","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.anai.2025.07.008_bib0033","article-title":"The paradoxes of asthma management: time for a new approach?","volume":"50","author":"O\u2019Byrne","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2025.07.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2021.01.024","article-title":"Real-world patterns and implications of short-acting \u03b2(2)-agonist use in patients with asthma in the United States","volume":"126","author":"Lugogo","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2025.07.008_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.anai.2025.07.008_bib0036","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/JAA.S408504","article-title":"Estimating inhaled corticosteroid exposure from short-acting \u03b22-agonist-inhaled corticosteroid rescue","volume":"16","author":"Lugogo","year":"2023","journal-title":"J Asthma Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.07.008_bib0037","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaip.2024.02.003","article-title":"Budesonide\/formoterol or budesonide\/albuterol as anti-inflammatory reliever therapy for asthma","volume":"12","author":"Lipworth","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625003485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625003485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:02:56Z","timestamp":1777608176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625003485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1081120625003485"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.07.008","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Albuterol\u2013budesonide rescue inhaler for asthma","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}